Table 2

Long-Term (5-Yr) Clinical Outcomes

AF Group (n = 349), Number of Patients With ≥1 Event (Cumulative 5-Year Incidence)CF Group (n = 351), Number of Patients With ≥1 Event (Cumulative 5-Year Incidence)HR (95% Cl)p Value
Primary endpoint
 Death/MI/stroke/ACS/HF65 (22.4)70 (24.7)0.94 (0.67–1.31)0.70
Secondary endpoint
 All-cause death30 (10.8)37 (12.5)0.81 (0.50–1.31)0.39
 MI6 (2.7)9 (3.6)0.66 (0.24–1.86)0.43
 Stroke11 (3.5)12 (4.2)0.92 (0.41–2.08)0.84
 Emergency hospitalization for ACS24 (9.0)16 (6.3)1.50 (0.79–2.82)0.21
 Hospitalization for heart failure14 (4.3)15 (6.0)0.91 (0.44–1.88)0.79
 Definite stent thrombosis0 (0)2 (0.7)0.16
 Major bleeding9 (3.3)14 (5.3)0.63 (0.27–1.45)0.28
 Target lesion revascularization34 (10.4)23 (8.5)1.51 (0.89–2.57)0.12
 Clinically driven19 (5.9)21 (7.9)0.89 (0.48–1.66)0.72
 Any coronary revascularization63 (19.6)49 (18.1)1.36 (0.93–1.97)0.11
 Clinically driven47 (15.1)46 (16.8)1.02 (0.68–1.53)0.94

Values are n (%). Number of patients with ≥1 event was evaluated during the entire follow-up period; the cumulative incidence was estimated at 5 years.

ACS = acute coronary syndrome(s); CI = confidence interval; HF = heart failure; HR = hazard ratio; MI = myocardial infarction; other abbreviations as in Table 1.